Fu D, Wang L, Chouairi F, Rose I, Abetov D, Miller A, et al. Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5-CD44+ cells. Nat Commun. 2020;11:84 pubmed publisher

Nacarelli T, Fukumoto T, Zundell J, Fatkhutdinov N, Jean S, Cadungog M, et al. NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer. Cancer Res. 2019;: pubmed publisher

Huch M, Dorrell C, Boj S, van Es J, Li V, van de Wetering M, et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 2013;494:247-50 pubmed publisher

Watson S, Morris T, Varro A, Michaeli D, Smith A. A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth. Gut. 1999;45:812-7 pubmed

Chowers M, Keller N, Tal R, Barshack I, Lang R, Bar Meir S, et al. Human gastrin: a Helicobacter pylori--specific growth factor. Gastroenterology. 1999;117:1113-8 pubmed

Konda Y, Kamimura H, Yokota H, Hayashi N, Sugano K, Takeuchi T. Gastrin stimulates the growth of gastric pit with less-differentiated features. Am J Physiol. 1999;277:G773-84 pubmed publisher

Saillan Barreau C, Dufresne M, Clerc P, Sanchez D, Corominola H, Moriscot C, et al. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes. 1999;48:2015-21 pubmed